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Nodavirus (NNV; Nodaviridae family, Betanodavirus genus), is one of the most threatening 
virus for teleost fish and causes the viral encephalopathy and retinopathy (VER) disease 
that alters brain and retina structure and function. Among marine fish, the European sea 
bass (Dicentrarchus labrax), a very relevant species in Mediterranean aquaculture, is one 
of the most susceptible species, being larvae and juvenile stages those suffering highest 
mortalities. Though some laboratory vaccines have been tested their transference to the 
market has been much reduced and with unknown efficacy. Thus, our aim was to generate 
an inactivated NNV vaccine for sea bass and evaluate the immunity and protection 
conferred. To this end, sea bass specimens of 10 g were intraperitoneally injected with UV-
inactivated NNV (iNNV) and after 1 month infected with a lethal dose of NNV. Antiviral 
activity and specific antibody levels were determined in serum samples as well as the fish 
protection. The vaccine elicited antiviral activity and antibody levels in sea bass specimens 
as well as increased the relative protection survival up to 57.9%. Interestingly, in specimen 
vaccinated with the iNNV vaccine the antibody levels were significantly increased in sea 
bass specimens 2 days after infection. This is one of the few NNV vaccines tested in sea 
bass and the protection conferred was very similar to other NNV vaccine types tested in 
other fish species. In conclusion, we have generated an effective iNNV vaccine that 
protects European sea bass specimens by increasing the antiviral activity as well as the 
antibody levels. More efforts are needed to generate potent anti-NNV vaccines that could 
be applied to the aquaculture sector. (Support: Grants AGL2013-43588-P and AGL2016-
74866-C3-1-R (MINECO and FEDER) and 19883/GERM/15 (Fundación Séneca de la Región 
de Murcia, Spain) are gratefully acknowledged). 
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